MARKET

HALO

HALO

Halozyme Thrp
NASDAQ
98.66
-2.01
-2.00%
After Hours: 98.25 -0.41 -0.42% 19:34 08/14 EDT
OPEN
100.35
PREV CLOSE
100.67
HIGH
100.83
LOW
98.13
VOLUME
1.66M
TURNOVER
--
52 WEEK HIGH
104.78
52 WEEK LOW
61.23
MARKET CAP
11.20B
P/E (TTM)
29.48
1D
5D
1M
3M
1Y
5Y
1D
Halozyme (HALO) Q2 2026 Earnings Call Transcript
The Motley Fool · 1d ago
Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
NASDAQ · 1d ago
Top 3 Health Care Stocks That May Implode In August
Benzinga · 3d ago
Ten large-cap healthcare stocks with strong Quant scores amid sector-wide rally
Seeking Alpha · 3d ago
What Halozyme Therapeutics (HALO) Guidance Raise Means For Valuation
Simply Wall St · 4d ago
Biotech Stocks At 52-Week Highs - HALO +20% On Q2 Results, FENC, AVLN, AMLX, CHE
NASDAQ · 5d ago
Weekly Report: what happened at HALO last week (0803-0807)?
Weekly Report · 5d ago
Halozyme Therapeutics (HALO) Is Up 24.9% After Record Q2, Higher 2026 Guidance And New ENHANZE Deals - Has The Bull Case Changed?
Simply Wall St · 6d ago
More
About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing solutions to improve patient experiences and outcomes for emerging and established therapies. The Company's commercially-validated solution, ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, is used to facilitate the subcutaneous delivery of injected drugs and fluids, with a focus on improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine ENHANZE with its partners’ proprietary compounds. It also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED. It also has a proprietary ultra-high concentration microparticle formulation technology for biologics, branded Hypercon.

Webull offers Halozyme Therapeutics, Inc. stock information, including NASDAQ: HALO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HALO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HALO stock methods without spending real money on the virtual paper trading platform.